Abstract: Embodiments of the present invention are directed to a tethering enforcement device controller and methods thereof. The tethering enforcement device controller (TEDC) is installed on a primary device, or otherwise known as the tethered device. The TEDC is configured to detect, control and block unauthorized or inappropriate tethering with a secondary device, or otherwise known as the tethering device, via either a native or a third-party tethering application, by retrieving a configuration file from a server associated with a wireless carrier. The configuration file typically includes customer profile and currently blacklisted package names of third-party tethering applications. The customer profile typically includes subscription information, including use of tethering services. If the customer is trying to tether and tethering is not allowed, then the TEDC will prevent the secondary device from tethering with the primary device.

Abstract: Methods for prevention or inhibition of the growth or metastasis of cancer cells in a subject are disclosed. One method comprises the step of administering to the subject a therapeutically effective amount of an antibody to the chemokine CCL25 and/or the chemokine receptor CCR9. Another method comprises the step of administering to the subject a therapeutically effective amount of an expression vector that expresses an antibody to the chemokine CCL25 and/or the chemokine receptor CCR9.

Abstract: Methods for diagnosing cancer in a subject are disclosed. The method includes detecting the level of expression of one or more cancer markers in a biological sample obtained from the subject; and comparing the level of expression of the one or more cancer markers in the biological sample to a normal level of expression of the one or more cancer markers. The one or more cancer markers comprises CXCL13 or CXCR5 or both CXCL13 and CXCR5. Also disclosed is a kit for detecting cancer or monitoring cancer progression.

Abstract: Methods for diagnosing cancer in a subject are disclosed. The method includes detecting the level of expression of one or more cancer markers in a biological sample obtained from the subject; and comparing the level of expression of the one or more cancer markers in the biological sample to a normal level of expression of the one or more cancer markers. The one or more cancer markers comprises CXCL13 or CXCR5 or both CXCL13 and CXCR5. Also disclosed is a kit for detecting cancer or monitoring cancer progression.

Abstract: Milled nanoparticles comprising a biologically active agent, at least one biopolymer and a coating containing at least one coating which is a polymer or ligand are produced using milling and coating techniques which have not previously been used for these applications.

Abstract: A system and accompanying method adapted to facilitate folder structure and authorization mirroring between a Document management System (DMS) and an Enterprise Resource Planning (ERP). An example method includes providing a first user option to view a representation of a database structure of a database application of an ERP system; displaying a second user option to select a portion of the representation of the database structure; and offering a third user option to create a folder structure for a Document Management System (DMS) based on the selected portion of the representation of the database structure. In a more specific embodiment, the method further includes providing a fourth user option to adjust permissions for users to access one or more folders of the folder structure based on permissions associated with a database object of the database structure.

Abstract: Methods for detecting cancer in a subject are disclosed. The method includes detecting the level of expression of one or more cancer markers in a biological sample obtained from the subject; and comparing the level of expression of the one or more cancer markers in the biological sample to a normal level of expression of the one or more cancer markers. The one or more cancer markers comprise CCL25 or CCR9 or both CCL25 and CCR9.

Abstract: Milled nanoparticles comprising a biologically active agent, at least one biopolymer and a coating containing at least one coating which is a polymer or ligand are produced using milling and coating techniques which have not previously been used for these applications.

Abstract: Methods for prevention or inhibition of the growth or metastasis of cancer cells in a subject are disclosed. One method comprises the step of administering to the subject a therapeutically effective amount of an antibody to the chemokine CXCL13 and/or the chemokine receptor CXCR5. Another method comprises the step of administering to the subject a therapeutically effective amount of an expression vector that expresses an antibody to the chemokine CXCL13 and/or the chemokine receptor CXCR5.

Abstract: Methods for prevention, treatment or inhibition of the growth or metastasis of cancer cells in a subject are disclosed. One method comprises the step of administering to the subject a therapeutically effective amount of tumor associated antigen binding ligand-coated planetary ball milled (PBM) nanoparticles containing a cytotoxic agent.

Abstract: The present disclosure is directed to techniques for efficient streaming SVD computation. In an embodiment, streaming SVD can be applied for streamed data and/or for streamed processing of data. In another embodiment, the streamed data can include time series data, data in motion, and data at rest, wherein the data at rest can include data from a database or a file and read in an ordered manner. More particularly, the disclosure is directed to an efficient and faster method of computation of streaming SVD for data sets such that errors including reconstruction error and loss of orthogonality are error bounded. The method avoids SVD re-computation of already computed data sets and ensures updates to the SVD model by incorporating only the changes introduced by the new entrant data sets.

Abstract: The present subject matter relates to a process of reforming a natural gas stream by steam. The reforming is carried out at a temperature within a predetermined range to form a substantially carbon monoxide free product mixture of hydrogen and natural gas. The reforming is carried out in presence of a nickel-based catalyst. The temperature is controlled in a range of about 350° C. to about 390° C. The reforming can be started or stopped or its rate can be varied, based on an outflow demand of the product mixture of hydrogen and natural gas.

Abstract: A system and accompanying method adapted to facilitate folder structure and authorization mirroring between a Document management System (DMS) and an Enterprise Resource Planning (ERP). An example method includes providing a first user option to view a representation of a database structure of a database application of an ERP system; displaying a second user option to select a portion of the representation of the database structure; and offering a third user option to create a folder structure for a Document Management System (DMS) based on the selected portion of the representation of the database structure. In a more specific embodiment, the method further includes providing a fourth user option to adjust permissions for users to access one or more folders of the folder structure based on permissions associated with a database object of the database structure.

Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.

Abstract: A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release active ingredient is from 1:10 to 1:15000 and the weight of modified release active ingredient per unit is from 500 mg to 1500 mg; a process for preparing the dosage form.

Abstract: Milled nanoparticles comprising a biologically active agent, at least one biopolymer and a coating containing at least one coating which is a polymer or ligand.

Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents; a process for preparing the dosage form.

Abstract: Methods for diagnosing cancer in a subject are disclosed. The method includes detecting the level of expression of one or more cancer markers in a biological sample obtained from the subject; and comparing the level of expression of the one or more cancer markers in the biological sample to a normal level of expression of the one or more cancer markers. The one or more cancer markers comprises CXCL13 or CXCR5 or both CXCL13 and CXCR5. Also disclosed is a kit for detecting cancer or monitoring cancer progression.

Abstract: Methods for prevention or inhibition of the growth or metastasis of cancer cells in a subject are disclosed. One method comprises the step of administering to the subject a therapeutically effective amount of an antibody to the chemokine CXCL13 and/or the chemokine receptor CXCR5. Another method comprises the step of administering to the subject a therapeutically effective amount of an expression vector that expresses an antibody to the chemokine CXCL13 and/or the chemokine receptor CXCR5.

Abstract: Methods for detecting cancer in a subject are disclosed. The method includes detecting the level of expression of one or more cancer markers in a biological sample obtained from the subject; and comparing the level of expression of the one or more cancer markers in the biological sample to a normal level of expression of the one or more cancer markers. The one or more cancer markers comprise CCL25 or CCR9 or both CCL25 and CCR9.